The Great Britain is witnessing a growing surge in interest surrounding copyright substances. Beyond the familiar use of psilocybin and LSD, investigators and adventurers are increasingly exploring less-charted frontiers, particularly copyright and the nascent cannabinoid, cannabigerol. The evolv